The Selling of Attention Deficit Disorder

The number of diagnoses soared as makers of the drugs used to treat attention deficit hyperactivity disorder found success with a two-decade marketing campaign.    

Source: NYT Health - December 14, 2013 Category: Consumer Health News Authors: By ALAN SCHWARZ Tags: Johnson & Johnson JNJ NYSE Drugs (Pharmaceuticals) Adderall (Drug) Attention Deficit Hyperactivity Disorder Shire PLC SHPG NASDAQ Source Type: news